Prescription Drug News and Research

RSS

Premiums increased at slowest rate since 1999

Health insurance premiums increased at the slowest pace in eight years, marking the fourth consecutive year premium increases have declined, according to a new report released today.

11 Sep 2007

Incidents of serious adverse drug events more than double

Incidents of serious adverse drug events including deaths reported to the U.S. Food and Drug Administration (FDA) rose by more than double over a seven year period and painkillers and immune-system boosters were responsible for most.

11 Sep 2007

Adverse drug events on the rise

The number of serious adverse drug events reported to the U.S. Food and Drug Administration (FDA) more than doubled between 1998 and 2005, as did deaths associated with adverse drug events, according to a report in the September 10 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

11 Sep 2007

Generic Coreg (carvedilol) approved in U.S.

The U.S. Food and Drug Administration has approved the first generic versions of Coreg (carvedilol). Coreg is a widely used medication that is FDA-approved to treat high blood pressure, mild to severe chronic heart failure and left ventricular dysfunction following a heart attack.

10 Sep 2007

U.S. may learn from Quebec's prescription drug plan

A new study published in The Milbank Quarterly finds a number of similarities between Canadian drug coverage and that of the United States, despite their publicized differences.

5 Sep 2007

Pharmacist Services Technical Advisory Coalition awarded grant from Community Pharmacy Foundation

The Pharmacist Services Technical Advisory Coalition (PSTAC), an alliance of seven national pharmacy organizations, has recently been awarded a grant from the Community Pharmacy Foundation to support an educational campaign on Current Procedural Terminology (CPT) codes used for Medication Therapy Management Services (MTMS) provided by pharmacists.

28 Aug 2007

Antipsychotic drug Risperdal approved for use in children

The Food and Drug Administration (FDA) in the U.S. has given approval for the antipsychotic drug Risperdal to be used to treat schizophrenia and bipolar disorder in children and teenagers.

23 Aug 2007

Warning - OTC diet supplement contains undeclared diet drug

Canadians are being warned that an over-the-counter (OTC) dietary supplement has been recalled because it contains a prescription drug used in the treatment of obesity.

21 Aug 2007

FDA warns against use of red yeast rice products promoted as high cholesterol treatment

The U.S. Food and Drug Administration is warning consumers not to buy or eat three red yeast rice products promoted and sold on Web sites.

12 Aug 2007

90 percent of seniors now have prescription drug coverage

More than 90 percent of Americans age 65 and older now have prescription drug coverage, compared to more than 75 percent who were covered in 2004, according to a University of Michigan analysis. And poor seniors are as likely to have coverage as the rich.

12 Aug 2007

Five ways to save 100,000 American lives

A new report says more than 100,000 American lives would be saved each year if people increased the use of five preventive services.

8 Aug 2007

Cannabis mouth spray eases pain of cancer patients

Canadian health authorities have given approval for a new cannabis-based painkiller for use with cancer patients.

8 Aug 2007

Health plan interventions control prescription drug expenditures

As national spending on prescription drugs rose faster than any other segment of health care spending, the health plan at Wake Forest University Baptist Medical Center was able to maintain constant spending, resulting in savings of more than $6.6 million over three years.

8 Aug 2007

Adverse effects of using prescription drugs with natural health products under-reported

The adverse effects of using prescription drugs side by side with natural health products (NHP) are being under-reported, so the potential risks may be underestimated by health-care professionals and the public, a study from the University of Alberta in Edmonton, Canada shows.

23 Jul 2007

Analysis of diabetes drugs

Most oral medications prescribed for type 2 diabetes are similarly effective for reducing blood glucose, but the drug metformin is less likely to cause weight gain and may be more likely than other treatments to decrease so-called bad cholesterol, according to a report funded by HHS Agency for Healthcare Research and Quality.

17 Jul 2007

Catalyst Pharmaceutical Partners starts U.S. phase II trial of CPP-109 in patients with cocaine dependence

Catalyst Pharmaceutical Partners, Inc. a specialty pharmaceutical company that acquires or in-licenses, develops and commercializes prescription drugs for the treatment of drug addiction, today announced that it has initiated its randomized, double-blind, placebo-controlled U.S. Phase II clinical trial of CPP-109 in patients with cocaine dependence.

11 Jul 2007

CMS issues final rule for Medicaid prescription drug reimbursements

CMS on Friday released a final rule that will change the Medicaid prescription drug reimbursement formula for pharmacies from being based on the average wholesale price to being based on the average manufacturer price, CongressDaily reports (Edney, CongressDaily, 7/10).

11 Jul 2007

National study to treat addiction to prescription pain medications

Researchers funded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, launched the first large-scale national study evaluating a treatment for addiction to prescription opioid analgesics (i.e., painkillers) such as Vicodin and OxyContin.

10 Jul 2007

Antidepressants not linked to birth defects

Two research studies published in The New England Journal of Medicine found taking SSRIs (selective serotonin reuptake inhibitors), anti-depression drugs, during pregnancy did not significantly increase the overall risk for most birth defects.

4 Jul 2007

Increase in prescription drug cost sharing associated with lower rates of drug treatment, adherence

A review of previous studies indicates that an increase in prescription drug cost sharing is associated with a decrease in drug spending and use of pharmacies; and for some chronic conditions, higher cost sharing is associated with greater use of expensive medical services, according to an article in the July 4 issue of JAMA: The Journal of the American Medical Association.

4 Jul 2007